Vornorexant: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|An article about the drug Vornorexant}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 123456789 | |||
| image = Vornorexant_skeletal.svg | |||
| image_size = 250px | |||
| image_alt = Skeletal structure of Vornorexant | |||
}} | |||
'''Vornorexant''' is a medication that acts as a dual orexin receptor antagonist. It is primarily investigated for its potential use in the treatment of insomnia and other sleep disorders. | |||
Vornorexant | ==Mechanism of Action== | ||
Vornorexant works by selectively blocking the action of [[orexin]] neuropeptides. Orexins, also known as hypocretins, are neuropeptides that regulate arousal, wakefulness, and appetite. By inhibiting the binding of orexins to their receptors, Vornorexant promotes sleep by reducing wakefulness. | |||
== | ==Pharmacokinetics== | ||
The pharmacokinetic profile of Vornorexant includes its absorption, distribution, metabolism, and excretion. After oral administration, Vornorexant is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the liver and excreted via the kidneys. | |||
Vornorexant has undergone several [[clinical trial]]s to | ==Clinical Trials== | ||
Vornorexant has undergone several [[clinical trial]]s to evaluate its efficacy and safety in treating insomnia. These trials assess various parameters such as sleep onset latency, total sleep time, and sleep quality. | |||
== | ==Side Effects== | ||
Common side effects of Vornorexant may include [[drowsiness]], [[headache]], and [[dizziness]]. As with any medication, it is important to monitor for adverse effects and consult a healthcare provider if they occur. | |||
==Potential Uses== | |||
While primarily studied for insomnia, Vornorexant may have potential applications in other conditions related to sleep disturbances, such as [[narcolepsy]] and [[shift work sleep disorder]]. | |||
== | ==Related pages== | ||
* [[Orexin receptor antagonist]] | |||
* [[Insomnia]] | |||
* [[Sleep disorder]] | |||
[[Category:Hypnotics and sedatives]] | |||
[[Category:Orexin receptor antagonists]] | |||
[[Category: | <gallery> | ||
[[Category: | File:Vornorexant skeletal.svg|Vornorexant | ||
</gallery> | |||
Latest revision as of 01:11, 20 February 2025
An article about the drug Vornorexant
| Vornorexant | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Vornorexant is a medication that acts as a dual orexin receptor antagonist. It is primarily investigated for its potential use in the treatment of insomnia and other sleep disorders.
Mechanism of Action[edit]
Vornorexant works by selectively blocking the action of orexin neuropeptides. Orexins, also known as hypocretins, are neuropeptides that regulate arousal, wakefulness, and appetite. By inhibiting the binding of orexins to their receptors, Vornorexant promotes sleep by reducing wakefulness.
Pharmacokinetics[edit]
The pharmacokinetic profile of Vornorexant includes its absorption, distribution, metabolism, and excretion. After oral administration, Vornorexant is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the liver and excreted via the kidneys.
Clinical Trials[edit]
Vornorexant has undergone several clinical trials to evaluate its efficacy and safety in treating insomnia. These trials assess various parameters such as sleep onset latency, total sleep time, and sleep quality.
Side Effects[edit]
Common side effects of Vornorexant may include drowsiness, headache, and dizziness. As with any medication, it is important to monitor for adverse effects and consult a healthcare provider if they occur.
Potential Uses[edit]
While primarily studied for insomnia, Vornorexant may have potential applications in other conditions related to sleep disturbances, such as narcolepsy and shift work sleep disorder.
Related pages[edit]
-
Vornorexant
